Information  X 
Enter a valid email address

Beximco Pharma Ltd GDR (BXP)

Related News

01-Apr-2022 11:05 AM

IN BRIEF : Beximco Pharmaceuticals renames Sanofi purchase as Synovia

Beximco Pharmaceuticals Ltd - Bangladesh-based pharmaceutical company - Changes name of the recently acquired subsidiary, Sanofi Bangladesh Ltd, to Synovia Pharma PLC, effective from 1 April. Beximco acquired the business from French biopharmaceutical
28-Jan-2021 09:46 AM

Beximco Pharmaceuticals sees 'material difference' in year-end results as profit rises in H1

Manufacturer of generic pharmaceutical Beximco Pharmaceuticals said it expected to see 'material difference' in its annual results after report a rise in half-year profit on increased sales For the six months ended 31 December 2020, pre-tax pr
13-Nov-2020 08:58 AM

Beximco Pharmaceuticals revenue grows 9.9% in Q1

Generic pharmaceutical products maker Beximco Pharmaceuticals said it had delivered year-on-year revenue growth of 9.9% in the first quarter of the current financial year, despite ongoing challenges posed by the COVID-19 pandemic. 'We continue to
23-Jun-2020 08:47 AM

Beximco Pharmaceuticals sees 'some impact' on profit from Covid-19 pandemic

Generic drugmaker Beximco Pharmaceuticals said it expected 'some impact' from the Covid-19 pandemic on annual profit. Following its previous announcement that annual revenue would be lower than expected, owing to the impact of the pandemic on
04-May-2020 09:55 AM

Beximco Pharmaceuticals expects Covid-19 pandemic to weigh on 4Q results following 'strong' sales

Pharmaceuticals company Beximco Pharmaceuticals said it expected to see some impact from the Covid-19 pandemic on fourth-quarter performance following 'strong' sales performance in the first three quarters of the year. Beximco Pharma, however,
09-Jul-2018 01:40 PM

Broker Forecast - Northland Capital issues a broker note on Beximco Pharmaceuticals Ltd

Northland Capital today reaffirms its buy investment rating on Beximco Pharmaceuticals Ltd (LON:BXP) and raised its price target to 84p (from 75p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
27-Apr-2018 07:56 AM

Beximco Pharmaceuticals profit up 15.6% as revenue jumps

Beximco Pharmaceuticals revealed third-quarter performance topped the prior period performance on both the top and bottom lines. For the period from January to March, net profit rose 15.6% to 603.1m Taka, from 521.5m Taka the same period a year ago as r
23-Apr-2018 02:20 PM

Broker Forecast - Northland Capital issues a broker note on Beximco Pharmaceuticals Ltd

Northland Capital today reaffirms its buy investment rating on Beximco Pharmaceuticals Ltd (LON:BXP) and set its price target at 75p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
19-Feb-2018 09:50 AM

Broker Forecast - Northland Capital issues a broker note on Beximco Pharmaceuticals Ltd

Northland Capital today initiates coverage of Beximco Pharmaceuticals Ltd (LON:BXP) with a buy investment rating and price target of 75p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
27-Dec-2017 08:03 AM

Beximco shareholders approve dividend

Beximco Pharmaceuticals has confirmed that all resolutions put to shareholders at the annual general meeting on 23 Dec were passed. The resolutions included the approval of a 12.5% cash dividend for the year ended on 30 Jun. The dividend will be paid
30-Nov-2017 01:15 PM

Beximco wins Scrip award

Beximco Pharmaceuticals has confirmed that the Company has won the award for the 'Best Company in an Emerging Market' at the Scrip Awards, presented in London. Chief Operating Officer of Beximco, accepted the award on behalf of the Company. Be
23-Nov-2017 01:16 PM

Beximco schedules AGM

Beximco Pharmaceuticals has confirmed that the Company intends to hold its Annual General Meeting on 23 December. At 1:16pm: (LON:BXP) Beximco Pharmaceuticals Ltd share price was 0p at 58.5p Story provided by StockMarketWire.com...
07-Nov-2017 09:26 AM

Beximco Pharma starts second product export to US

Beximco Pharmaceuticals has started the export of Sotalol Hydrochloride (80 mg, 120 mg and 160 mg), a generic version of the cardiovascular drug Betapace, to the US. This is the second product from Beximco Pharma to be exported to the US Following the
06-Nov-2017 01:50 PM

Beximco pre-tax profits up

Beximco Pharmaceuticals has reported that pre-tax profit increased 12.8% to BDT 2,891.5m (£27.50m) for the 12 month period ended 30 June 2017, compared to BDT 2,564.3m or £25.24m for the previous year. Net sales increased to BDT 15,508.8m (&p
18-Sep-2017 07:31 AM

Beximco Pharma starts Canada exports

Beximco Pharmaceuticals has started the export of Olopatadine, an ophthalmic product for treating the symptoms of eye allergy, to Canada. The manufacturer of generic pharmaceutical products and active pharmaceutical ingredients said this followed the a
25-Jul-2017 08:20 AM

FDA approves Beximco Pharma's muscle relaxant

Beximco Pharmaceuticals has received approval for its Methocarbamol tablets (500 mg and 750 mg) from the US Food and Drug Administration. The product is a generic equivalent to the muscle relaxant Robaxin tablets (500 mg and 750 mg), produced by Auxiliu
25-Jul-2017 07:06 AM

FDA approves Beximco Pharma's muscle relaxant

Story provided by StockMarketWire.com...
28-Apr-2017 09:23 AM

Beximco Pharma pre-tax profits up

Beximco Pharmaceuticals' pre-tax profits rose to Taka683,956,000 in the three months to the end of January - up from Taka537,234,000 a year ago. Third quarter net sales revenues increased to Taka3,814,008,000 from Taka3,397,157,000 last time. At 9
27-Jan-2017 07:37 AM

Beximco Pharmaceuticals profits jump

Beximco Pharmaceuticals posts pre-tax profits of BDT1,464.1m for the six months to the end of December - up from BDT1,243.6m last time. Net sales increased by 13.6% to BDT7,630.6m and after-tax profits rose buy 17.8% to BDT1,112.9m. Managing director Na
19-Dec-2016 07:40 AM

Beximco Pharma's Metformin gets FDA approval

Beximco Pharmaceuticals has received approval for its Metformin Hydrochloride extended-release tablets (500 mg and 750 mg) from the US Food and Drug Administration (US FDA). This product is the generic equivalent to Bristol-Myers Squibb's (BMS) Glu
15-Nov-2016 09:34 AM

Beximco Pharma operating profits up

Beximco Pharmaceuticals posts operating profits of Taka863,579,000 for the first quarter to the end of September -up from Taka716,280,000 a year ago. Net sales revenues rose to Taka3,765,598,000 from Taka3,385,704,000. At 9:34am: (LON:BXP) Beximco Phar
25-Oct-2016 07:23 AM

Beximco Pharma gets second US FDA approval

Beximco Pharmaceuticals has received US Food and Drug Administration approval for Sotalol Hydrochloride, a generic version of the cardiovascular drug Betapace, following submission of an abbreviated new drug application (ANDA) in June 2014. This is the
20-Oct-2016 09:27 AM

Beximco Pharma net sales up

Beximco Pharmaceuticals' net sales increased to BDT12,965.5 million (£111.95 million) in the year to January-December 2015 registering a year-on-year growth rate of 15.7% (2014: BDT11,206.9 million (£92.28 million) Export sales register
09-May-2016 08:12 AM

Beximco Pharma pre-tax profits up

Beximco Pharmaceuticals posts pre-tax profits of BDT2,337.1 million for the year to the end of December - 10.8% up on last time. Net sales increased to BDT 12,965.5 million - a year-on-year growth rate of 15.7% with export sales up 68.3%. Corporate hig
27-Oct-2015 09:41 AM

Beximco sales revenues rise

Beximco Pharmaceuticals' net sales revenues rose to Taka9,634.9m in the nine months to the end of September - up from Taka8,268.7m last time. Net sales revenues for the three months to the end of September were Taka3,385.7m - up from Taka2,946.4m.

a d v e r t i s e m e n t